Figure 1.
Proportion of ncMono within the leukemia-associated myeloid cell-enriched compartment of patient samples. (A) Mann-Whitney U test demonstrating a significantly increased proportion of ncMono within the leukemia-associated myeloid compartment (CD45+CD19–CD10–CD22–CD56–CD3–CD66b–) of patient diagnostic BM samples (n = 89) compared with remission BM control samples (n = 4). (B) The proportion of ncMono within the leukemia-associated myeloid compartment of PB samples significantly correlated with that in BM samples using Spearman correlation.

Proportion of ncMono within the leukemia-associated myeloid cell-enriched compartment of patient samples. (A) Mann-Whitney U test demonstrating a significantly increased proportion of ncMono within the leukemia-associated myeloid compartment (CD45+CD19CD10CD22CD56CD3CD66b) of patient diagnostic BM samples (n = 89) compared with remission BM control samples (n = 4). (B) The proportion of ncMono within the leukemia-associated myeloid compartment of PB samples significantly correlated with that in BM samples using Spearman correlation.

Close Modal

or Create an Account

Close Modal
Close Modal